Marshall Wace’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$382K Sell
2025
Q2
$437K Sell
2025
Q1
$1.76M Buy
2024
Q2
Sell
2024
Q1
$3.9M Buy
2023
Q2
Sell
2023
Q1
$3.43M Buy
2022
Q3
Sell
2022
Q2
$869K Buy